PATENT CLAIM ANALYSIS

Application Number: 16405581
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-10
Patent Classification: ["514", "307000"]

Abstract:
Provided herein, inter alia, are compound and methods of treating cancer by inhibiting HDAC8.

Claim (Index 25):
The method of  claim 24 , wherein said non-mutated p53 cancer has increased HDAC8 activity or HDAC8 expression compared to a mutated p53 cancer.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 100.0
- Lexical Diversity: 1.0625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15042012', '16027029', '14992396', '15421258', '15123232']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8114799305089773
- 35 USC 102 Novelty (BERT): 0.6076571900407916
- Combined Prediction Score: 0.7910976564621587
- Mean Citation Score: 512.8317040000002
- Max Citation Score: 827.5081
- Similarity Product: 448.2781588947951

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test